Skip to main content
Premium Trial:

Request an Annual Quote

ImaGenes to Distribute Invitrogen Clones in Europe

NEW YORK (GenomeWeb News) – Invitrogen has signed up ImaGenes as a distributor for its Gateway ORF clones in Europe, ImaGenes said.
 
The Gateway system is used in restriction-free cloning and protein expression. ImaGenes said it plans to distribute the clones through its web-based clone portal, called GenomeCube.
 
The Berlin-based company is a spin-off of RZPD German Resource Center for Genome Research, a former Invitrogen distributor, and through a tri-lateral agreement ImaGenes has taken over the European distribution rights from RZPD. The center shut down in July 2007 and transferred its services operations to ImaGenes and Atlas Biolabs.
 
Financial terms of the agreement were not released.

The Scan

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.

Study Explores Animated Digital Message Approach to Communicate Genetic Test Results to Family Members

In the Journal of Genetic Counseling, the approach showed promise in participants presented with a hypothetical scenario related to a familial hereditary breast and ovarian cancer syndrome diagnosis.

Computational Tool Predicts Mammalian Messenger RNA Degradation Rates

A tool called Saluki, trained with mouse and human messenger RNA data, appears to improve mRNA half-life predictions by taking RNA and genetic features into account, a Genome Biology paper reports.

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.